Midcareer Investigator Award in Patient-Oriented Research in Aging

以患者为导向的老龄化研究中职业生涯调查员奖

基本信息

  • 批准号:
    10615121
  • 负责人:
  • 金额:
    $ 16.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-15 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary This is an application for the renewal of a K24 mentoring award for patient-oriented research (POR) from Anne Cappola, MD, ScM, Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn). The candidate has had a strong record of mentorship, leadership, and research productivity during the initial award period. Her research program encompasses POR studies at the intersection of endocrinology and geriatrics. The scientific goals of this proposal are to investigate the age- specificity of the cardiovascular risks of mild subclinical hypothyroidism and to examine thyroid stimulating hormone (TSH) testing and levothyroxine prescribing patterns in older individuals. These studies are required to support a change in the upper limit of the TSH reference range for individuals aged 65 years and older. This change would improve the health and reduce health care costs for millions of older Americans through prevention of unnecessary prescription of thyroid hormone treatment, reduction in excessive TSH monitoring, and avoidance of iatrogenic thyrotoxicosis. The mentoring goals of this application are to support the candidate’s six current K-award mentees’ transition to R01 funded independence and to engage a new generation of Penn fellows and junior faculty to conduct POR in aging. The career development goal of this application is to support the candidate’s professional development and program building in clinical investigation. This will be achieved through focused learning about biomedical informatics, engagement in Penn’s CTSA to enhance lifespan research, and ongoing leadership to promote the visibility of aging research in the endocrine community. The institutional environment for clinical and translational science at Penn is outstanding, and the proposal integrates multiple programs from Penn’s CTSA. The Department of Medicine at Penn has made a substantial commitment, including protected time and dedicated space, toward the candidate’s sustained success as a patient-oriented researcher responsible for training a new generation of junior investigators who conduct POR in older participants. Renewal of this application will allow the candidate to cement the programmatic gains achieved during the initial award period and to assure their sustainability after the renewal has completed.
项目总结

项目成果

期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Incorporating Baseline Outcome Data in Individual Participant Data Meta-Analysis of Non-randomized Studies.
  • DOI:
    10.3389/fpsyt.2022.774251
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Syrogiannouli L;Wildisen L;Meuwese C;Bauer DC;Cappola AR;Gussekloo J;den Elzen WPJ;Trompet S;Westendorp RGJ;Jukema JW;Ferrucci L;Ceresini G;Åsvold BO;Chaker L;Peeters RP;Imaizumi M;Ohishi W;Vaes B;Völzke H;Sgarbi JA;Walsh JP;Dullaart RPF;Bakker SJL;Iacoviello M;Rodondi N;Del Giovane C
  • 通讯作者:
    Del Giovane C
Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism.
  • DOI:
    10.3389/fendo.2021.795492
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Gencer B;Cappola AR;Rodondi N;Collet TH
  • 通讯作者:
    Collet TH
Using Natural Language Processing to Extract and Classify Symptoms Among Patients with Thyroid Dysfunction.
使用自然语言处理对甲状腺功能障碍患者的症状进行提取和分类。
  • DOI:
    10.3233/shti231038
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hwang,Sy;Reddy,Sujatha;Wainwright,Katherine;Schriver,Emily;Cappola,Anne;Mowery,Danielle
  • 通讯作者:
    Mowery,Danielle
Barriers to and solutions for representative inclusion across the lifespan and in life course research: The need for structural competency highlighted by the COVID-19 pandemic.
  • DOI:
    10.1017/cts.2022.510
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    LeCroy, Madison N.;Potter, Lindsey N.;Bandeen-Roche, Karen;Bianco, Monica E.;Cappola, Anne R.;Carter, Ebony B.;Dayan, Peter S.;Eckstrom, Elizabeth;Edwards, Dorothy F.;Farabi, Sarah S.;Fisher, Sheehan D.;Giordano, Judy;Hanson, Heidi A.;Jenkins, Emerald;Juhn, Young;Kaskel, Frederick;Stake, Christine E.;Reeds, Dominic N.;Schleiss, Mark R.;Wafford, Q. Eileen;McColley, Susanna A.
  • 通讯作者:
    McColley, Susanna A.
Subclinical thyroid dysfunction and incident diabetes: a systematic review and an individual participant data analysis of prospective cohort studies.
  • DOI:
    10.1530/eje-22-0523
  • 发表时间:
    2022-11-01
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Alwan H;Villoz F;Feller M;Dullaart RPF;Bakker SJL;Peeters RP;Kavousi M;Bauer DC;Cappola AR;Yeap BB;Walsh JP;Brown SJ;Ceresini G;Ferrucci L;Gussekloo J;Trompet S;Iacoviello M;Moon JH;Razvi S;Bensenor IM;Azizi F;Amouzegar A;Valdés S;Colomo N;Wareham NJ;Jukema JW;Westendorp RGJ;Kim KW;Rodondi N;Del Giovane C
  • 通讯作者:
    Del Giovane C
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANNE R CAPPOLA其他文献

ANNE R CAPPOLA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANNE R CAPPOLA', 18)}}的其他基金

Levothyroxine Dosing in Older Individuals
老年人的左旋甲状腺素剂量
  • 批准号:
    10638015
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
Developing Oral LT3 Therapy for Heart Failure
开发治疗心力衰竭的口服 LT3 疗法
  • 批准号:
    10026340
  • 财政年份:
    2019
  • 资助金额:
    $ 16.19万
  • 项目类别:
Developing Oral LT3 Therapy for Heart Failure
开发治疗心力衰竭的口服 LT3 疗法
  • 批准号:
    10164851
  • 财政年份:
    2019
  • 资助金额:
    $ 16.19万
  • 项目类别:
Developing Oral LT3 Therapy for Heart Failure
开发治疗心力衰竭的口服 LT3 疗法
  • 批准号:
    10400936
  • 财政年份:
    2019
  • 资助金额:
    $ 16.19万
  • 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
  • 批准号:
    10444914
  • 财政年份:
    2013
  • 资助金额:
    $ 16.19万
  • 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
  • 批准号:
    8510209
  • 财政年份:
    2013
  • 资助金额:
    $ 16.19万
  • 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
  • 批准号:
    10055441
  • 财政年份:
    2013
  • 资助金额:
    $ 16.19万
  • 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
  • 批准号:
    8699642
  • 财政年份:
    2013
  • 资助金额:
    $ 16.19万
  • 项目类别:
Ghrelin and Strength Training in Frail Elderly
生长素释放肽与体弱老年人的力量训练
  • 批准号:
    8332309
  • 财政年份:
    2011
  • 资助金额:
    $ 16.19万
  • 项目类别:
Ghrelin and Strength Training in Frail Elderly
生长素释放肽与体弱老年人的力量训练
  • 批准号:
    8249657
  • 财政年份:
    2011
  • 资助金额:
    $ 16.19万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了